Abstract
Hippotherapy is used in physiotherapy as a treatment that takes advantage of the unique characteristics of the horses' walk impulses and triggers movement responses in patients sitting on the horse's back. The research evidence for application of hippotherapy at people with neurological deficits and disabilities is sparse. Multiple sclerosis (MS) is a chronic and inflammatory disease that affects the neurons of the Central Nervous System. The aim of this review article was to presents the effect of hippotherapy at people with MS. PubMed, Science Direct, Pedro, Total and National Institute Hi.K.E.R., and Google Scholar were searched from 2005 to 2021. Out of 271 studies, 14 were included. The results showed that hippotherapy has a positive impact on the motor function, the walking cycle, the endurance, the balance, and the orthostatic control of people with MS. Further research must be done in a greater scale and investigate the way hippotherapy affects the quality of life, the self-confidence and the social inclusion of people with MS. In summary, the application of hippotherapy in people with MS contributes positively to the progression of the disease and enhances the functionality of individuals.
Highlights
The results showed that hippotherapy has a positive impact on the motor function, the walking cycle, the endurance, the balance, and the orthostatic control of people with Multiple sclerosis (MS)
This review aims to address this by examining the effect of hippotherapy in patients with MS, as far as fatigue, balance, torso control, gait and quality of life is concerned
The results showed improvement in four of thirteen subjects from phase A1 to B and in five subjects from phase A1 to A2, balance was observed in eight subjects, three subjects improved in SRLMT
Summary
In the U.S about 400,000 people suffer from this disease. It is one of the most common causes of neurological disability that mainly affects ages 20 to 50 years old, with average age of establishment being 32 years [2]. MS is two to three times more common in women than in men. Populations such as Alaska's indigenous Inuit, Norway's Lapons, Australia's Avorines and New Zealand's Maori almost never show MS. According to epidemiological studies smokers have a 40-80% greater risk of developing MS [1] and are more than three times more likely to experience a transition of recurrent MS to a secondary prolapse, compared to non-smokers
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Science and Research Archive
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
